335
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

Intrauterine growth restriction: the controversial role of perinatal adipocytokines in the prediction of metabolic adult disease

&
Pages 2577-2582 | Received 28 Aug 2019, Accepted 16 Sep 2019, Published online: 25 Sep 2019

References

  • Rosenberg A. The IUGR newborn. Semin Perinatol. 2008;32(3):219–224.
  • Barouki R, Gluckman PD, Grandjean P, et al. Developmental origins of non-communicable disease: implications for research and public health. Environ Health. 2012;11:42.
  • Gluckman PD, Hanson MA, Low FM. The role of developmental plasticity and epigenetics in human health. Birth Defects Res C Embryo Today. 2011;93(1):12–18.
  • Li Y, Gonzalez P, Zhang L. Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions. Prog Neurobiol. 2012;98(2):145–165.
  • Yajnik CS, Lubree HG, Rege SS, et al. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab. 2002;87(12):5575–5580.
  • Ibáñez L, Lopez-Bermejo A, Suárez L, et al. Visceral adiposity without overweight in children born small for gestational age. J Clin Endocrinol Metab. 2008;93(6):2079–2083.
  • Boiko J, Jaquet D, Chevenne D, et al. In situ lipolytic regulation in subjects born small for gestational age. Int J Obes (Lond). 2005;29(6):565–570.
  • Jaquet D, Gaboriau A, Czernichow P, et al. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab. 2000;85(4):1401–1406.
  • Eriksson JG, Lindi V, Uusitupa M, et al. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes. 2002;51(7):2321–2324.
  • Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia. 2003;46(12):1594–1603.
  • Briana DD, Malamitsi-Puchner A. Intrauterine growth restriction and adult disease: the role of adipocytokines. Eur J Endocrinol. 2009;160(3):337–347.
  • McMillen IC, Muhlhausler BS, Duffield JA, et al. Prenatal programming of postnatal obesity: fetal nutrition and the regulation of leptin synthesis and secretion before birth. Proc Nutr Soc. 2004;63(3):405–412.
  • Schöndorf T, Maiworm A, Emmison N, et al. Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk. Clin Lab. 2005;51(9–10):489–494.
  • Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656–660.
  • Gualillo O, Caminos J, Blanco M, et al. Ghrelin, a novel placental-derived hormone. Endocrinology. 2001;142(2):788–794.
  • Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002;13(1):18–23.
  • Briana DD, Boutsikou M, Baka S, et al. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Neonatology. 2008;93(3):153–157.
  • Cox CM, D’Agostino SL, Miller MK, et al. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol. 2006;296(1):177–189.
  • Malamitsi-Puchner A, Gourgiotis D, Boutsikou M, et al. Circulating apelin concentrations in mother/infant pairs at term. Acta Paediatr. 2007;96(12):1751–1754.
  • Sethi JK, Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med. 2005;11(8):344–347.
  • Malamitsi-Puchner A, Briana DD, Gourgiotis D, et al. Blood visfatin concentrations in normal full-term pregnancies. Acta Paediatr. 2007;96(4):526–529.
  • Briana DD, Boutsikou M, Gourgiotis D, et al. Role of visfatin, insulin-like growth factor-I and insulin in fetal growth. J Perinat Med. 2007;35(4):326–329.
  • Yang RZ, Lee MJ, Hu H, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006;290(6):E1253–E1261.
  • Youn BS, Klöting N, Kratzsch J, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes. 2008;57(2):372–377.
  • Wang Y, Kim KA, Kim JH, et al. Pref-1, a preadipocyte secreted factor that inhibits adipogenesis. J Nutr. 2006;136(12):2953–2956.
  • Cao H, Sekiya M, Ertunc ME, et al. Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab. 2013;17(5):768–778.
  • D’Anna R, Baviera G, Giordano D, et al. Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. Acta Obstet Gynecol Scand. 2008;87(12):1370–1373.
  • Pighetti M, Tommaselli GA, D’Elia A, et al. Maternal serum and umbilical cord blood leptin concentrations with fetal growth restriction. Obstet Gynecol. 2003;102(3):535–543.
  • Kyriakakou M, Malamitsi-Puchner A, Militsi H, et al. Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers. Eur J Endocrinol. 2008;158(3):343–348.
  • Grosfeld A, Andre J, Hauguel-De Mouzon SH, et al. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem. 2002;277(45):42953–42957.
  • Martínez-Cordero C, Amador-Licona N, Guízar-Mendoza JM, et al. Body fat at birth and cord blood levels of insulin, adiponectin, leptin, and insulin-like growth factor-I in small-for-gestational-age infants. Arch Med Res. 2006;37(4):490–494.
  • Ibáñez L, Sebastiani G, Lopez-Bermejo A, et al. Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth. J Clin Endocrinol Metab. 2008;93(7):2774–2778.
  • Takaya J, Yamato F, Higashino H, et al. Intracellular magnesium and adipokines in umbilical cord plasma and infant birth size. Pediatr Res. 2007;62(6):700–703.
  • Farquhar J, Heiman M, Wong AC, et al. Elevated umbilical cord ghrelin concentrations in small for gestational age neonates. J Clin Endocrinol Metab. 2003;88(9):4324–4327.
  • Malamitsi-Puchner A, Briana DD, Boutsikou M, et al. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics. 2007;119(6):e1314–e1318.
  • Briana DD, Boutsikou M, Baka S, et al. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Metabolism. 2011;60(4):486–490.
  • Díaz M, Bassols J, Aragonés G, et al. Decreased placental expression of pre-adipocyte factor-1 in children born small-for-gestational-age: association to early postnatal weight gain. Placenta. 2013;34(4):331–334.
  • Zhou Q, Li J, Wang H, et al. Serum preadipocyte factor-1 is increased in fetuses of pregnancy complicated with severe preeclampsia. Clin Chim Acta. 2013;424:212–215.
  • Briana DD, Papathanasiou AE, Gavrili S, et al. Preadipocyte factor-1 in maternal, umbilical cord serum and breast milk: the impact of fetal growth. Cytokine. 2019;114:143–148.
  • Papathanasiou AE, Briana DD, Gavrili S, et al. Cord blood fatty acid-binding protein-4 levels are upregulated at both ends of the birthweight spectrum. Acta Paediatr. 2019.
  • Joung KE, Cataltepe SU, Michael Z, et al. Cord blood adipocyte fatty acid-binding protein levels correlate with gestational age and birth weight in neonates. J Clin Endocrinol Metab. 2017;102(5):1606–1613.
  • Papathanasiou AE, Malamitsi-Puchner A, Gavrili S, et al. Perinatal lipocalin-2 profile at the extremes of fetal growth. J Mater Fetal Neonat Med. 2019:1–7.
  • Tungalagsuvd A, Matsuzaki T, Iwasa T, et al. The expression of orexigenic and anorexigenic factors in middle-aged female rats that had been subjected to prenatal undernutrition. Int J Dev Neurosci. 2016;49:1–5.
  • Juvet C, Simeoni U, Yzydorczyk C, et al. Effect of early postnatal nutrition on chronic kidney disease and arterial hypertension in adulthood: a narrative review. J Dev Orig Health Dis. 2018;9(6):598–614.
  • Jaquet D, Leger J, Tabone MD, et al. High serum leptin concentrations during catch-up growth of children born with intrauterine growth retardation. J Clin Endocrinol Metab. 1999;84(6):1949–1953.
  • Cianfarani S, Martinez C, Maiorana A, et al. Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal catch-up growth. J Clin Endocrinol Metab. 2004;89(3):1346–1351.
  • Takaya K, Ariyasu H, Kanamoto N, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab. 2000;85(12):4908–4911.
  • Méndez-Ramírez F, Barbosa-Sabanero G, Romero-Gutiérrez G, et al. Ghrelin in small-for-gestational age (SGA) newborn babies: a cross-sectional study. Clin Endocrinol (Oxf). 2009;70(1):41–46.
  • Li L, Yang G, Li Q, et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes. 2006;114(10):544–548.
  • Jaquet D, Deghmoun S, Chevenne D, et al. Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia. 2005;48(5):849–855.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.